Literature DB >> 18207698

CD4 T cells: Balancing the coming and going of autoimmune-mediated inflammation in the CNS.

Bonnie N Dittel1.   

Abstract

The regulation of the inflammatory response is often viewed as very complex with many cellular players. The type of immune response generated is dependent upon the nature of the immune stimulation. In autoimmunity, one of the most important players is the CD4 T cell. The CD4 T cell lineage consists of a number of phenotypically and functionally distinct subsets. The unique functions of CD4 T cells are often mediated by soluble factors, which shape the nature of the immune response. In a T cell-mediated autoimmune response, such as in multiple sclerosis (MS), the CD4 T cell is thought to orchestrate and drive the immune response resulting in inflammation within the central nervous system (CNS). The extent of the inflammation must be tightly controlled or permanent tissue damage will occur. In MS, progressive debilitating disease is thought to be due to such damage. In addition to promoting inflammation, the CD4 T cell lineage also has the capacity to prevent and downmodulate inflammation. This is accomplished by specific CD4 T regulatory (Treg) cells and other regulatory feedback mechanisms. Thus although the complexity of the immune system is often viewed as too complicated for a nonimmunologist to fully understand, there are patterns that emerge that make the system clearer. One such pattern is the balance that the immune system must always maintain. A weak or slow immune response to a pathogen can lead to sickness and even death, while a too robust or uncontrolled immune response can lead to tissue damage, and for autoimmune diseases, ultimately death. How CD4 T cells maintain this balance will be discussed in the context of the CNS autoimmune disease MS.

Entities:  

Mesh:

Year:  2008        PMID: 18207698      PMCID: PMC2376206          DOI: 10.1016/j.bbi.2007.11.010

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  76 in total

Review 1.  The cannabinoid system and immune modulation.

Authors:  Thomas W Klein; Cathy Newton; Kellie Larsen; Lily Lu; Izabella Perkins; Liang Nong; Herman Friedman
Journal:  J Leukoc Biol       Date:  2003-07-01       Impact factor: 4.962

Review 2.  Microtubule-dependent transport in neurons: steps towards an understanding of regulation, function and dysfunction.

Authors:  Brian W Guzik; Lawrence S B Goldstein
Journal:  Curr Opin Cell Biol       Date:  2004-08       Impact factor: 8.382

3.  Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system.

Authors:  J D Sedgwick; S Schwender; H Imrich; R Dörries; G W Butcher; V ter Meulen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

4.  Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity.

Authors:  M B Powell; D Mitchell; J Lederman; J Buckmeier; S S Zamvil; M Graham; N H Ruddle; L Steinman
Journal:  Int Immunol       Date:  1990       Impact factor: 4.823

5.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

6.  Gamma delta T cell regulation of IFN-gamma production by central nervous system-infiltrating encephalitogenic T cells: correlation with recovery from experimental autoimmune encephalomyelitis.

Authors:  Eugene D Ponomarev; Marina Novikova; Maryam Yassai; Marian Szczepanik; Jack Gorski; Bonnie N Dittel
Journal:  J Immunol       Date:  2004-08-01       Impact factor: 5.422

Review 7.  Fas and Fas ligand: lpr and gld mutations.

Authors:  S Nagata; T Suda
Journal:  Immunol Today       Date:  1995-01

8.  Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation.

Authors:  M Stein; S Keshav; N Harris; S Gordon
Journal:  J Exp Med       Date:  1992-07-01       Impact factor: 14.307

9.  Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.

Authors:  WanJun Chen; Wenwen Jin; Neil Hardegen; Ke-Jian Lei; Li Li; Nancy Marinos; George McGrady; Sharon M Wahl
Journal:  J Exp Med       Date:  2003-12-15       Impact factor: 14.307

10.  Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia.

Authors:  Julia M Edgar; Mark McLaughlin; Donald Yool; Su-Chun Zhang; Jill H Fowler; Paul Montague; Jennifer A Barrie; Mailis C McCulloch; Ian D Duncan; James Garbern; Klaus A Nave; Ian R Griffiths
Journal:  J Cell Biol       Date:  2004-06-28       Impact factor: 10.539

View more
  31 in total

1.  Naturally presented peptides on major histocompatibility complex I and II molecules eluted from central nervous system of multiple sclerosis patients.

Authors:  Nicolas Fissolo; Sabrina Haag; Katrien L de Graaf; Oliver Drews; Stefan Stevanovic; Hans Georg Rammensee; Robert Weissert
Journal:  Mol Cell Proteomics       Date:  2009-06-16       Impact factor: 5.911

2.  ZSTK474, a novel PI3K inhibitor, modulates human CD14+ monocyte-derived dendritic cell functions and suppresses experimental autoimmune encephalomyelitis.

Authors:  Zhenyi Xue; Wen Li; Huafeng Wang; Biao Huang; Zhenzhen Ge; Chao Gu; Ying Liu; Kai Zhang; Juhong Yang; Rong Han; Meiyu Peng; Yan Li; Da Zhang; Yurong Da; Zhi Yao; Rongxin Zhang
Journal:  J Mol Med (Berl)       Date:  2014-05-22       Impact factor: 4.599

3.  Two discreet subsets of CD8 T cells modulate PLP(91-110) induced experimental autoimmune encephalomyelitis in HLA-DR3 transgenic mice.

Authors:  Ashutosh K Mangalam; David Luckey; Shailendra Giri; Michele Smart; Larry R Pease; Moses Rodriguez; Chella S David
Journal:  J Autoimmun       Date:  2012-03-28       Impact factor: 7.094

4.  Targeted knock-in mice expressing mutations of CD28 reveal an essential pathway for costimulation.

Authors:  Lindzy F Dodson; Jonathan S Boomer; Christine M Deppong; Dulari D Shah; Julia Sim; Traci L Bricker; John H Russell; Jonathan M Green
Journal:  Mol Cell Biol       Date:  2009-04-27       Impact factor: 4.272

5.  Analysis of IL-6, IL-1β and TNF-α production in monocytes isolated from multiple sclerosis patients treated with disease modifying drugs.

Authors:  Sarah E Fiedler; Joshua D George; Haley N Love; Edward Kim; Rebecca Spain; Dennis Bourdette; Sonemany Salinthone
Journal:  J Syst Integr Neurosci       Date:  2017-06-17

6.  Regulation of Mycobacterium-specific mononuclear cell responses by 25-hydroxyvitamin D3.

Authors:  Corwin D Nelson; Brian J Nonnecke; Timothy A Reinhardt; W Ray Waters; Donald C Beitz; John D Lippolis
Journal:  PLoS One       Date:  2011-06-28       Impact factor: 3.240

7.  Coordinated gene expression of Th17- and Treg-associated molecules correlated with resolution of the monophasic experimental autoimmune uveitis.

Authors:  Xiuzhi Jia; Minghui Hu; Caihong Wang; Chunyu Wang; Fengyun Zhang; Qinglian Han; Ruibo Zhao; Qi Huang; Hongwei Xu; Huiping Yuan; Huan Ren
Journal:  Mol Vis       Date:  2011-06-07       Impact factor: 2.367

8.  Increase in Th17 and T-reg lymphocytes and decrease of IL22 correlate with the recovery phase of acute EAE in rat.

Authors:  Beatriz Almolda; Manuela Costa; Maria Montoya; Berta González; Bernardo Castellano
Journal:  PLoS One       Date:  2011-11-07       Impact factor: 3.240

9.  In Vivo Inhibition of MicroRNA-326 in a NOD.H-2h4 Mouse Model of Autoimmune Thyroiditis.

Authors:  Na Zhao; Zhenzhen Wang; Xuejiao Cui; Shuo Wang; Chenling Fan; Yushu Li; Zhongyan Shan; Weiping Teng
Journal:  Front Immunol       Date:  2021-06-01       Impact factor: 7.561

10.  CD8⁺CXCR5⁺ T cells regulate pathology in the genital tract.

Authors:  Janina Jiang; Cheryl I Champion; Bo Wei; Guangchao Liu; Kathleen A Kelly
Journal:  Infect Dis Obstet Gynecol       Date:  2013-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.